Basal Cell Adenocarcinoma is a type of cancer that originates from the glandular cells in the basal layer of the skin. It is a slow-growing and relatively common malignancy primarily affecting the sweat and oil glands. This cancer typically develops in sun-exposed areas of the body such as the head, face, and neck.
Basal Cell Adenocarcinoma is characterized by abnormal cellular growth in the basal layer of the skin's epidermis. These cancerous cells tend to invade the surrounding tissue, causing damage to nearby structures and potentially spreading to distant sites through metastasis. The exact cause of Basal Cell Adenocarcinoma is not fully understood, but exposure to ultraviolet (UV) radiation from the sun, genetics, and certain risk factors such as fair skin, a history of sunburns, and chronic inflammation have been associated with its development.
Symptoms of Basal Cell Adenocarcinoma may include the appearance of a pearly or translucent bump, a sore that does not heal or bleeds easily, a shiny pink or red growth with visible blood vessels, or a flat, scaly, and crusty lesion. While this cancer rarely spreads to other parts of the body, it can cause disfigurement, tissue destruction, and in rare cases, invade deeper layers of the skin or bones.
Treatment options for Basal Cell Adenocarcinoma vary depending on the size, location, and stage of the cancer. Common approaches include surgical excision, cryotherapy (freezing), radiation therapy, topical medications, and Mohs surgery – a specialized technique that ensures the complete removal of the cancerous cells while preserving healthy tissue. Regular follow-up visits with a healthcare professional are essential to monitor for possible recurrences or
